Alessandro Mandurino Mirizzi (@ale_mm1988) 's Twitter Profile
Alessandro Mandurino Mirizzi

@ale_mm1988

Interventional Cardiologist at Vito Fazzi Hospital, Lecce 🇮🇹

ID: 1091763707116441603

linkhttp://linkedin.com/in/alessandro-mandurino-mirizzi-2b2947167 calendar_today02-02-2019 18:22:06

67 Tweet

483 Followers

393 Following

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

In this study of patients with tricuspid regurgitation (TR) who underwent TEER, the evaluation of the leaflet-to-annulus index, which is calculated from tricuspid leaflet length and annular dimension, was effective for predicting significant residual TR. ow.ly/Isjp50Jvc7R

In this study of patients with tricuspid regurgitation (TR) who underwent TEER, the evaluation of the leaflet-to-annulus index, which is calculated from tricuspid leaflet length and annular dimension, was effective for predicting significant residual TR. ow.ly/Isjp50Jvc7R
Heart_BMJ (@heart_bmj) 's Twitter Profile Photo

Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial heart.bmj.com/content/early/…

Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial

heart.bmj.com/content/early/…
Hellenic Journal of Cardiology (@hjcardiology) 's Twitter Profile Photo

The residual iatrogenic #Atrial Septal Defect after #MitraClip for #MVR and its #hemodynamic importance Data published Hellenic Journal of Cardiology demonstrate that this effect is not clinically significant bit.ly/HJC_AtrialSept… #CardioTwitter HCSYoung #VHD Alessandro Mandurino Mirizzi Gabriele Crimi, MD.

The residual iatrogenic #Atrial Septal Defect after #MitraClip for #MVR and its #hemodynamic importance

Data published <a href="/HjCardiology/">Hellenic Journal of Cardiology</a> demonstrate that this effect is not clinically significant
bit.ly/HJC_AtrialSept…

#CardioTwitter <a href="/hcs_young/">HCSYoung</a> #VHD <a href="/Ale_MM1988/">Alessandro Mandurino Mirizzi</a> <a href="/crimigabriele/">Gabriele Crimi, MD.</a>
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

In this study of patients with moderate-to-severe or severe mitral regurgitation, echocardiographic parameters, including the presence of disproportionate severe MR, did not predict outcomes after MitraClip implantation. #EIJBestOf #mitralregurgitation ow.ly/2YQL50JTE7u

In this study of patients with moderate-to-severe or severe mitral regurgitation, echocardiographic parameters, including the presence of disproportionate severe MR, did not predict outcomes after MitraClip implantation. #EIJBestOf #mitralregurgitation ow.ly/2YQL50JTE7u
Gregg W. Stone MD (@greggwstone) 's Twitter Profile Photo

Fantastic slide, I agree. MitraClip in HFrEF would be way to the left on the top line, probably a hazard ratio of 0.25, given that in COAPT it reduced mortality by 38% at 2 years on top of max tolerated class I GDMT. Add devices (eg CRT, ICD, TEER) for the next paper.

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

TAVI is twenty years old: performed, investigated, debated, with several questions looking for an answer. However, twenty years is a quite remarkable milestone, and the progress of other valve interventional procedures is far behind. A summary of the trials to date. #ESCCongress

TAVI is twenty years old: performed, investigated, debated, with several questions looking for an answer. However, twenty years is a quite remarkable milestone, and the progress of other valve interventional procedures is far behind. A summary of the trials to date. #ESCCongress
Reviews in Cardiovascular Medicine (@rcmjournal) 's Twitter Profile Photo

#RCM - Vol. 22 No. 1 #Callforread 🏨Review--Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives Alessandro Mandurino Mirizzi Lorenzo Tua Luca Arzuffi Gabriele Crimi, MD. #MitraClip #MR #PH Full text: imrpress.com/journal/RCM/22…

#RCM - Vol. 22 No. 1
#Callforread 
🏨Review--Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives
<a href="/Ale_MM1988/">Alessandro Mandurino Mirizzi</a> <a href="/lorenzotua/">Lorenzo Tua</a> <a href="/l_arzuffi/">Luca Arzuffi</a> <a href="/crimigabriele/">Gabriele Crimi, MD.</a> 

#MitraClip #MR #PH
Full text:
imrpress.com/journal/RCM/22…
Gregg W. Stone MD (@greggwstone) 's Twitter Profile Photo

Our publ in today's JACC CV Int on non-fatal peri-procedural compls after LM revasc in EXCEL. Rate 11.9% after PCI and 45.4% after CABG. Highly predictive of 30d and late death after both procedures. Reducing procedural complications can improve outcomes after both PCI and CABG.

Our publ in today's JACC CV Int on non-fatal peri-procedural compls after LM revasc in EXCEL. Rate  11.9% after PCI and 45.4% after CABG. Highly predictive of 30d and late death after both procedures. Reducing procedural complications can improve outcomes after both PCI and CABG.
NEJM (@nejm) 's Twitter Profile Photo

In RENOVATE-COMPLEX-PCI, a randomized trial of imaging-guided or angiography-guided PCI for complex coronary lesion revascularization procedures, imaging-guided PCI led to a lower risk of target-vessel failure than angiography-guided PCI. nej.md/3Y2zION #ACC23/#WCCardio

In RENOVATE-COMPLEX-PCI, a randomized trial of imaging-guided or angiography-guided PCI for complex coronary lesion revascularization procedures, imaging-guided PCI led to a lower risk of target-vessel failure than angiography-guided PCI. nej.md/3Y2zION 
#ACC23/#WCCardio
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

In this study of patients undergoing PCI for chronic coronary syndromes, prasugrel/ticagrelor showed similar safety and efficacy to clopidogrel at 1 year with no significant difference in death, MI, bleeding, stroke and target vessel revascularization. ow.ly/it2M50NnPYN

In this study of patients undergoing PCI for chronic coronary syndromes, prasugrel/ticagrelor showed similar safety and efficacy to clopidogrel at 1 year with no significant difference in death, MI, bleeding, stroke and target vessel revascularization. ow.ly/it2M50NnPYN
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Three notable class 3 recommendations against routine periodic testing in asymptomatic CCD patients from AHA/ACC guidelines: 1) no benefit with coronary CTA or stress testing 2) no benefit of periodic assessment of LVEF 3) harm with coronary angiography jacc.org/doi/10.1016/j.…

Three notable class 3 recommendations against routine periodic testing in asymptomatic CCD patients from AHA/ACC guidelines:
1) no benefit with coronary CTA or stress testing 
2) no benefit of periodic assessment of LVEF
3) harm with coronary angiography
jacc.org/doi/10.1016/j.…
JCM MDPI (@jcm_mdpi) 's Twitter Profile Photo

#mdpijcm 👏Editor’s Choice Review Contrast-Associated #Acute Kidney Injury,by Dr. Alessandro Mandurino-Mirizzi Alessandro Mandurino Mirizzi; Dr. Andrea Munafò Andrea Munafò and Dr. Gabriele Crimi Gabriele Crimi, MD. Views 5300, Citations 18💐💐 mdpi.com/1585364

#mdpijcm
👏Editor’s Choice Review
Contrast-Associated #Acute Kidney Injury,by Dr. Alessandro Mandurino-Mirizzi <a href="/Ale_MM1988/">Alessandro Mandurino Mirizzi</a>; Dr. Andrea Munafò <a href="/andrea_muna/">Andrea Munafò</a> and Dr. Gabriele Crimi <a href="/crimigabriele/">Gabriele Crimi, MD.</a>

Views 5300, Citations 18💐💐
mdpi.com/1585364
Alessandro Mandurino Mirizzi (@ale_mm1988) 's Twitter Profile Photo

Our network metanalysis (42 RCTs, 30219 pts) comparing OCT, IVUS, FFR, iFR, angio for guidance to PCI, updated w/ the latest RCTs, on International Journal of Cardiology: 🔸OCT, IVUS, FFR ⬇️cardiac death vs angio 🔸OCT, IVUS ⬇️TLF, TVR, TLR, ST vs angio 🔸OCT ⬇️TLF vs FFR and iFR. sciencedirect.com/science/articl…

Our network metanalysis (42 RCTs, 30219 pts) comparing OCT, IVUS, FFR, iFR, angio for guidance to PCI, updated w/ the latest RCTs, on <a href="/IJCardio/">International Journal of Cardiology</a>:
🔸OCT, IVUS, FFR ⬇️cardiac death vs angio
🔸OCT, IVUS ⬇️TLF, TVR, TLR, ST vs angio
🔸OCT ⬇️TLF vs FFR and iFR. 
sciencedirect.com/science/articl…
Claudio Montalto (@mdmontalto) 's Twitter Profile Photo

🚨 Just published in EuroIntervention! 🫀 Outcomes of complex/high-risk #PCI #CHIP in patients undergoing #TAVI – insights from the #ASCoP registry 📊 Graphical abstract 👇 📖 Read: eurointervention.pcronline.com/article/outcom… #CardioTwitter #StructuralHeart

🚨 Just published in <a href="/EuroInterventio/">EuroIntervention</a>!
🫀 Outcomes of complex/high-risk #PCI #CHIP in patients undergoing #TAVI – insights from the #ASCoP registry

📊 Graphical abstract 👇
📖 Read: eurointervention.pcronline.com/article/outcom…

#CardioTwitter #StructuralHeart